Systemic Therapy for Stage IV Melanoma: Current Standards, Questions, and Investigations

Expert commentary from Allison Betof Warner, MD, PhD, on selecting optimal frontline therapy for metastatic melanoma, from Clinical Care Options (CCO)

Allison Betof Warner, MD, PhD Released: February 17, 2021

Gain key clinical insights fast, with this short slideset from CCO on therapy for high-risk, resectable melanoma and metastatic melanoma.

Michael A. Davies, MD, PhD Ahmad Tarhini, MD, PhD Released: November 6, 2020

In this slideset from Clinical Care Options (CCO), Ahmad A. Tarhini, MD, PhD offers insight on optimizing adjuvant therapy for high-risk melanoma

Ahmad Tarhini, MD, PhD Released: November 3, 2020

Expert-authored commentary from Clinical Care Options (CCO) on factors to consider when using adjuvant targeted therapy for high-risk resected melanoma with BRAF mutations

Douglas B. Johnson, MD, MSCI Released: October 19, 2020